SCHLEIFER LEONARD S
Insider CIK 1218629 · REGN President & CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2025-12-31 | 2026-01-05 | 28,570 | — | $0 | 595,077 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2025-12-31 | 2026-01-05 | 28,570 | — | $0 | 243,093 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-31 | 2026-01-05 | 28,570 | $772.09 | $22.06M | 214,523 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2025-12-09 | 2025-12-11 | 172,723 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-09 | 2025-12-11 | 155,145 | $701.51 | $108.84M | 214,523 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2025-12-09 | 2025-12-11 | 172,723 | $555.67 | $95.98M | 369,668 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | C Conversion deriv | 2024-06-12 | 2024-06-13 | 1,000 | — | $0 | 14,775 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-12 | 2024-06-13 | 1,000 | $1025.27 | $1.03M | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-12 | 2024-06-13 | 14,879 | $1015.30 | $15.11M | 40,255 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-12 | 2024-06-13 | 270 | $1016.62 | $274.5K | 39,985 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | C Conversion | 2024-06-12 | 2024-06-13 | 1,000 | — | $0 | 1,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-11 | 2024-06-13 | 1,743 | $1016.04 | $1.77M | 55,134 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-11 | 2024-06-13 | 7,321 | $1015.28 | $7.43M | 56,877 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-06-06 | 2024-06-10 | 787 | $1015.02 | $798.8K | 64,198 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-17 | 2024-05-17 | 143 | $980.07 | $140.2K | 466,877 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-17 | 2024-05-17 | 22,687 | $979.22 | $22.22M | 467,020 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 228 | $987.46 | $225.1K | 397,558 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 103 | $986.57 | $101.6K | 397,786 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 281 | $985.72 | $277.0K | 397,889 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 305 | $984.00 | $300.1K | 398,170 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 250 | $983.91 | $246.0K | 398,475 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 235 | $982.66 | $230.9K | 398,725 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 1,081 | $981.50 | $1.06M | 398,960 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 295 | $980.64 | $289.3K | 400,041 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 7,864 | $979.05 | $7.70M | 400,336 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-15 | 2024-05-15 | 299 | $988.76 | $295.6K | 397,259 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-14 | 2024-05-15 | 2,302 | $980.10 | $2.26M | 408,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-05-14 | 2024-05-15 | 22,698 | $979.16 | $22.22M | 410,502 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-05-13 | 2024-05-15 | 203,204 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-05-13 | 2024-05-15 | 144,433 | $976.79 | $141.08M | 433,200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-05-13 | 2024-05-15 | 203,204 | $399.66 | $81.21M | 577,633 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-12-11 | 2023-12-13 | 25,155 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-12-11 | 2023-12-13 | 25,155 | — | $0 | 387,270 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-11 | 2023-12-13 | 12,841 | $844.09 | $10.84M | 374,429 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2023-05-15 | 2023-05-17 | 53,807 | — | $0 | 64,985 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2023-05-15 | 2023-05-17 | 53,807 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-06 | 2022-04-07 | 2,653 | $710.04 | $1.88M | 11,178 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-04-05 | 2022-04-07 | 4,461 | $710.05 | $3.17M | 13,831 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-03-31 | 2022-04-04 | 2,886 | $710.01 | $2.05M | 18,292 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-11-19 | 2021-11-19 | 281,250 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-11-19 | 2021-11-19 | 239,063 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-11-19 | 2021-11-19 | 173,491 | $651.96 | $113.11M | 370,318 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-11-19 | 2021-11-19 | 281,250 | $179.13 | $50.38M | 651,568 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-11-19 | 2021-11-19 | 185,646 | $651.96 | $121.03M | 465,922 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-11-19 | 2021-11-19 | 239,063 | $270.43 | $64.65M | 543,809 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-19 | 2021-08-20 | 10,000 | $660.03 | $6.60M | 21,178 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-18 | 2021-08-20 | 200,000 | $650.03 | $130.01M | 304,746 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 146 | $616.70 | $90.0K | 40,861 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 171 | $615.54 | $105.3K | 41,007 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 258 | $617.79 | $159.4K | 40,603 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 90 | $618.82 | $55.7K | 40,513 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 34 | $619.83 | $21.1K | 40,479 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 96 | $620.36 | $59.6K | 40,383 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 287 | $621.76 | $178.4K | 40,096 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 924 | $622.44 | $575.1K | 39,172 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 2,393 | $623.66 | $1.49M | 36,779 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 1,862 | $624.42 | $1.16M | 34,917 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 1,355 | $625.19 | $847.1K | 33,562 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 295 | $626.15 | $184.7K | 33,267 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 1,111 | $627.51 | $697.2K | 32,156 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 303 | $629.54 | $190.8K | 31,178 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-16 | 2021-08-17 | 675 | $628.41 | $424.2K | 31,481 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-06 | 2021-08-10 | 160,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-06 | 2021-08-10 | 240,000 | — | $0 | 160,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-06 | 2021-08-10 | 160,000 | $52.03 | $8.32M | 596,176 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-08-06 | 2021-08-10 | 91,430 | $607.51 | $55.54M | 504,746 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-08-06 | 2021-08-10 | 137,145 | $607.51 | $83.32M | 436,176 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-06 | 2021-08-10 | 240,000 | $52.03 | $12.49M | 573,321 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2021-05-19 | 2021-08-10 | 41,178 | — | $0 | 41,178 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | G Gift | 2021-05-19 | 2021-08-10 | 41,178 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-12-31 | 2021-01-05 | 620,270 | — | $0 | 620,270 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 2,329 | $557.51 | $1.30M | 623,092 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 638 | $577.27 | $368.3K | 474,499 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 1,728 | $576.51 | $996.2K | 475,137 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 2,196 | $575.48 | $1.26M | 476,865 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 4,390 | $574.59 | $2.52M | 479,061 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 10,014 | $573.27 | $5.74M | 483,451 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 19,984 | $572.47 | $11.44M | 493,465 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 15,542 | $571.49 | $8.88M | 513,449 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 20,267 | $570.49 | $11.56M | 528,991 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 19,982 | $569.52 | $11.38M | 549,258 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 18,021 | $568.58 | $10.25M | 569,240 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 9,359 | $567.57 | $5.31M | 587,261 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 5,810 | $566.51 | $3.29M | 596,620 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 3,032 | $565.67 | $1.72M | 602,430 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 779 | $564.41 | $439.7K | 605,462 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 2,549 | $563.51 | $1.44M | 606,241 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 1,394 | $562.75 | $784.5K | 608,790 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 3,994 | $561.24 | $2.24M | 610,184 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 3,391 | $560.68 | $1.90M | 614,178 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 1,361 | $559.52 | $761.5K | 617,569 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-12 | 2020-05-13 | 4,162 | $558.35 | $2.32M | 618,930 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-11 | 2020-05-13 | 187,500 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-11 | 2020-05-13 | 125,000 | — | $0 | 187,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-05-11 | 2020-05-13 | 96,947 | $571.43 | $55.40M | 625,421 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-11 | 2020-05-13 | 187,500 | $30.63 | $5.74M | 722,368 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-05-11 | 2020-05-13 | 64,631 | $571.43 | $36.93M | 534,868 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-11 | 2020-05-13 | 125,000 | $30.63 | $3.83M | 599,499 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2019-12-12 | 2019-12-13 | 187,500 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2019-12-12 | 2019-12-13 | 124,900 | — | $0 | 187,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2019-12-12 | 2019-12-13 | 187,500 | $21.25 | $3.98M | 571,708 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2019-12-12 | 2019-12-13 | 97,209 | $377.16 | $36.66M | 474,499 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2019-12-12 | 2019-12-13 | 64,754 | $377.16 | $24.42M | 384,208 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2019-12-12 | 2019-12-13 | 124,900 | $21.25 | $2.65M | 448,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2019-12-11 | 2019-12-13 | 81,278 | — | $0 | 81,278 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2019-12-11 | 2019-12-13 | 25,155 | — | $0 | 25,155 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2019-03-21 | 2019-03-22 | 100 | — | $0 | 312,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2019-03-21 | 2019-03-22 | 100 | $21.25 | $2.1K | 424,062 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-12-13 | 2018-12-14 | 125,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2018-12-13 | 2018-12-14 | 187,500 | — | $0 | 125,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-12-13 | 2018-12-14 | 187,500 | $16.80 | $3.15M | 459,093 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2018-12-13 | 2018-12-14 | 125,000 | $16.80 | $2.10M | 488,014 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2018-12-13 | 2018-12-14 | 96,079 | $377.31 | $36.25M | 363,014 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2018-12-13 | 2018-12-14 | 64,052 | $377.31 | $24.17M | 423,962 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-12-12 | 2018-12-14 | 129,013 | — | $0 | 129,013 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2017-12-13 | 2017-12-13 | 250,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2017-12-13 | 2017-12-13 | 14,230 | $385.08 | $5.48M | 393,179 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2017-12-13 | 2017-12-13 | 250,000 | $21.92 | $5.48M | 407,409 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2017-12-13 | 2017-12-13 | 121,586 | $385.08 | $46.82M | 271,593 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-12-12 | 2017-12-13 | 139,474 | — | $0 | 139,474 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-12-16 | 2016-12-19 | 146,815 | — | $0 | 146,815 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-12-15 | 2016-12-19 | 250,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-12-15 | 2016-12-19 | 250,000 | $20.32 | $5.08M | 292,806 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2016-12-15 | 2016-12-19 | 122,032 | $380.09 | $46.38M | 157,409 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2016-12-15 | 2016-12-19 | 13,365 | $380.09 | $5.08M | 279,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-12-16 | 2015-12-18 | 172,723 | — | $0 | 172,723 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-09-02 | 2015-09-03 | 7,226 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-09-02 | 2015-09-03 | 7,226 | $402.69 | $2.91M | 49,313 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-09-02 | 2015-09-03 | 762 | $506.37 | $385.9K | 42,806 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-09-02 | 2015-09-03 | 5,745 | $506.37 | $2.91M | 43,568 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2015-01-02 | 2015-01-05 | 1,500 | — | $0 | 15,775 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 300 | $409.28 | $122.8K | 803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 403 | $410.47 | $165.4K | 400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 100 | $416.00 | $41.6K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 200 | $412.23 | $82.4K | 200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2015-01-02 | 2015-01-05 | 1,500 | — | $0 | 1,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 397 | $408.64 | $162.2K | 1,103 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-01-02 | 2015-01-05 | 100 | $413.88 | $41.4K | 100 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 203,204 | — | $0 | 203,204 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 240,000 | — | $0 | 400,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-12 | 2014-11-12 | 4,860 | $401.12 | $1.95M | 42,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-12 | 2014-11-12 | 37,464 | $400.22 | $14.99M | 46,947 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-11 | 2014-11-12 | 3,493 | $400.00 | $1.40M | 84,411 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-31 | 2014-11-04 | 3,453 | $400.11 | $1.38M | 87,904 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 1,789 | $409.43 | $732.5K | 91,457 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 2,400 | $408.62 | $980.7K | 93,246 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 4,350 | $407.31 | $1.77M | 95,646 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 14,052 | $406.50 | $5.71M | 99,996 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 5,900 | $405.76 | $2.39M | 114,048 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 2,250 | $404.46 | $910.0K | 119,948 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 12,250 | $403.38 | $4.94M | 122,198 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 3,318 | $402.54 | $1.34M | 134,448 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 10,381 | $401.45 | $4.17M | 137,766 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 12,322 | $400.52 | $4.94M | 148,147 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-10-28 | 2014-10-29 | 100 | $410.00 | $41.0K | 91,357 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-10-27 | 2014-10-29 | 7,226 | — | $0 | 7,226 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-10-27 | 2014-10-29 | 250,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-10-27 | 2014-10-29 | 6,808 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-10-27 | 2014-10-29 | 5,145 | $402.69 | $2.07M | 43,750 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-10-27 | 2014-10-29 | 125,198 | $402.69 | $50.42M | 160,469 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-10-27 | 2014-10-29 | 7,226 | $402.69 | $2.91M | 285,667 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-10-27 | 2014-10-29 | 250,000 | $11.64 | $2.91M | 292,893 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-10-27 | 2014-10-29 | 857 | $402.69 | $345.1K | 42,893 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-10-27 | 2014-10-29 | 6,808 | $304.38 | $2.07M | 48,895 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-12-13 | 2013-12-17 | 239,063 | — | $0 | 239,063 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-12-13 | 2013-12-17 | 187,500 | — | $0 | 312,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 4,594 | $313.44 | $1.44M | 45,281 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 1,374 | $312.44 | $429.3K | 49,875 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 2,200 | $314.31 | $691.5K | 43,081 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 400 | $315.39 | $126.2K | 42,681 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 100 | $316.13 | $31.6K | 42,581 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-10-02 | 2013-10-03 | 494 | $317.34 | $156.8K | 42,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-10-01 | 2013-10-03 | 1,801 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-10-01 | 2013-10-03 | 27,475 | — | $0 | 1,801 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-10-01 | 2013-10-03 | 599 | $313.58 | $187.8K | 51,249 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-10-01 | 2013-10-03 | 637 | $313.58 | $199.8K | 51,848 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-10-01 | 2013-10-03 | 1,801 | $111.01 | $199.9K | 52,485 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-10-01 | 2013-10-03 | 9,152 | $313.58 | $2.87M | 50,684 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-10-01 | 2013-10-03 | 9,726 | $313.58 | $3.05M | 59,836 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-10-01 | 2013-10-03 | 27,475 | $111.01 | $3.05M | 69,562 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 5,103 | $303.38 | $1.55M | 72,363 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 1,200 | $309.80 | $371.8K | 43,887 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 1,200 | $308.70 | $370.4K | 45,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 1,157 | $307.20 | $355.4K | 46,287 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 7,248 | $306.47 | $2.22M | 47,444 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 7,026 | $305.50 | $2.15M | 54,692 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 10,645 | $304.36 | $3.24M | 61,718 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 1,800 | $310.14 | $558.3K | 42,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 15,625 | $302.68 | $4.73M | 77,466 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 15,611 | $301.45 | $4.71M | 93,091 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-19 | 2013-09-20 | 36,334 | $300.33 | $10.91M | 108,702 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-09-18 | 2013-09-20 | 218,389 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-09-18 | 2013-09-20 | 6,808 | — | $0 | 6,808 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-09-18 | 2013-09-20 | 108,632 | $304.38 | $33.07M | 145,036 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-09-18 | 2013-09-20 | 6,808 | $304.38 | $2.07M | 253,668 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-09-18 | 2013-09-20 | 218,389 | $9.49 | $2.07M | 260,476 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion deriv | 2013-09-09 | 2013-09-11 | 5,000 | — | $0 | 17,275 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | C Conversion | 2013-09-09 | 2013-09-11 | 5,000 | — | $0 | 5,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-09 | 2013-09-11 | 3,600 | $275.04 | $990.1K | 1,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-09 | 2013-09-11 | 200 | $277.12 | $55.4K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-09 | 2013-09-11 | 1,200 | $276.47 | $331.8K | 200 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 500 | $227.40 | $113.7K | 120,337 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 622 | $228.04 | $141.8K | 119,715 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 300 | $250.06 | $75.0K | 42,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 600 | $249.45 | $149.7K | 42,387 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 900 | $248.72 | $223.8K | 42,987 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 450 | $247.32 | $111.3K | 43,887 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 8,700 | $246.13 | $2.14M | 44,337 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 5,383 | $245.55 | $1.32M | 53,037 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 9,814 | $244.49 | $2.40M | 58,420 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 11,938 | $243.41 | $2.91M | 68,234 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 4,695 | $242.54 | $1.14M | 80,172 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 3,350 | $241.25 | $808.2K | 84,867 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 7,295 | $240.44 | $1.75M | 88,217 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 4,087 | $239.68 | $979.6K | 95,512 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 3,089 | $238.65 | $737.2K | 99,599 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 2,300 | $237.31 | $545.8K | 102,688 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 3,327 | $236.47 | $786.7K | 104,988 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 400 | $235.75 | $94.3K | 108,315 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 5,000 | $233.34 | $1.17M | 108,715 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 700 | $232.18 | $162.5K | 113,715 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 5,300 | $231.18 | $1.23M | 114,415 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 20,400 | $225.01 | $4.59M | 121,687 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-01 | 2013-05-03 | 850 | $226.26 | $192.3K | 120,837 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-19 | 2013-03-21 | 3,655 | $175.02 | $639.7K | 142,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-13 | 2013-03-15 | 4,662 | $175.01 | $815.9K | 145,742 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-07 | 2013-03-07 | 3,534 | $175.13 | $618.9K | 150,404 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-06 | 2013-03-07 | 8,200 | $176.10 | $1.44M | 153,938 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-06 | 2013-03-07 | 60,803 | $175.28 | $10.66M | 162,138 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-03-05 | 2013-03-07 | 19,146 | $175.21 | $3.35M | 222,941 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | G Gift | 2012-12-24 | 2013-03-07 | 59,271 | — | $0 | 242,087 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-12-14 | 2012-12-17 | 281,250 | — | $0 | 281,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-12-14 | 2012-12-17 | 187,500 | — | $0 | 312,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-11-16 | 2012-11-19 | 43,757 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-11-16 | 2012-11-19 | 32,272 | $150.51 | $4.86M | 306,648 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-11-16 | 2012-11-19 | 5,290 | $150.51 | $796.2K | 301,358 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-11-16 | 2012-11-19 | 43,757 | $111.01 | $4.86M | 338,920 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | G Gift | 2012-10-25 | 2012-11-19 | 75,938 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-05-01 | 2012-05-02 | 58,494 | $134.55 | $7.87M | 325,534 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-05-01 | 2012-05-02 | 39,106 | $135.29 | $5.29M | 286,428 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-05-01 | 2012-05-02 | 100 | $136.57 | $13.7K | 286,328 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-05-01 | 2012-05-02 | 2,300 | $133.86 | $307.9K | 384,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-15 | 2012-02-15 | 6,257 | $111.01 | $694.6K | 386,328 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-02-14 | 2012-02-15 | 27,475 | — | $0 | 29,276 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-02-14 | 2012-02-15 | 43,757 | — | $0 | 43,757 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-02-14 | 2012-02-15 | 1,801 | — | $0 | 1,801 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-02-14 | 2012-02-15 | 250,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-02-14 | 2012-02-15 | 15,384 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-02-14 | 2012-02-15 | 234,616 | — | $0 | 15,384 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-14 | 2012-02-15 | 43,757 | $111.01 | $4.86M | 474,018 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-02-14 | 2012-02-15 | 234,616 | $13.00 | $3.05M | 390,679 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-14 | 2012-02-15 | 1,801 | $111.01 | $199.9K | 392,585 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-02-14 | 2012-02-15 | 15,384 | $13.00 | $200.0K | 394,386 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-14 | 2012-02-15 | 95,016 | $111.01 | $10.55M | 379,002 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-02-14 | 2012-02-15 | 250,000 | $19.43 | $4.86M | 517,775 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-14 | 2012-02-15 | 95,429 | $111.01 | $10.59M | 267,775 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-02-14 | 2012-02-15 | 27,475 | $111.01 | $3.05M | 363,204 | SEC↗ |